Sweden
MEDS is an online pharmacy authorized by the Swedish Medical Products Agency, offering both prescription and non-prescription medicines for customers, their families, and even their pets. In addition to pharmaceuticals, MEDS offers a wide range of health and beauty products, all aimed at improving well-being. Established in 2017 and officially launched in 2018, MEDS distinguishes itself from traditional pharmacies by not having a physical store, instead focusing on direct delivery to customers' doorsteps.
The startup prides itself on the convenience it offers, enabling customers to obtain their necessary medications and other pharmacy products without ever having to leave their homes. With a focus on e-commerce and healthcare, MEDS is at the forefront of offering accessible and efficient pharmaceutical services to its customers.
The latest notable development for MEDS came on 10 April 2022, when the company received a Secondary Market investment from Centripetal. This investment marks a significant step for MEDS in its journey to revolutionize the pharmacy and e-commerce industries, further solidifying its position in the market as a convenient and reliable provider of essential healthcare products.
In summary, MEDS Apotek presents a compelling opportunity for venture capital investors seeking to support innovative startups in the e-commerce and healthcare sectors. Its focus on leveraging technology to meet the evolving needs of customers, backed by a recent investment from Centripetal, positions MEDS as a promising player in the pharmaceutical industry.
